MAT2A and neoplasm: We demonstrated that limiting methionine intake or targeting MAT2A efficiently suppresses the tumorigenicity of GBM tumorsphere cells, thus present a novel perspective on hypoxia-mediated maintenance of tumor-initiating cells.